Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

By KATIE ADAMS
This roundup will be published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, resignation or layoff that you would like to share for this roundup or the MedCity Moves podcast, please reach out to moves@medcitynews.com.

Here is a selection of recent executive hires, promotions, departures and layoffs occurring across the healthcare industry.

Hires
Aledade, an independent primary care network focused on value-based care, brought Rosemary Weldon onto its team as its new chief product officer. She spent the last decade at CVS Health, where she most recently served as vice president of digital health product management.

Amgen welcomed James Bradner to its C-suite, where he now serves as chief scientific officer and executive vice president of research and development. He succeeds David Reese, who has transitioned into the role of chief technology officer at Amgen. Before taking his new role, Bradner was president of the Novartis Institutes for BioMedical Research.

B.well Connected Health, a startup seeking to improve the patient experience, appointed Sarah Jones as its chief outcomes officer. In the past, she has held leadership roles at a few other healthcare companies, including Best Buy Health and Firefly Health.

CommonSpirit Health named Terika Richardson as its new COO. She has held leadership roles at various health systems for nearly two decades, most recently serving as COO of Ardent Health Services.

Genomic testing company Foundation Medicine appointed Dan Malarek as CEO. He most recently served as global head of marketing & customer insights at Roche Diagnostics.

Stand Up To Cancer, a nonprofit that supports funding for cancer research, appointed Julian Adams as CEO. He is a longtime oncology researcher and pharmaceutical industry executive whose work has focused on cancer-related drug discovery and development. In the past, Adams has held roles at Boehringer Ingelheim, Millennium Pharmaceuticals (now Takeda Oncology) and Infinity Pharmaceuticals.

UC San Diego Health created a new role for its C-suite — the health system welcomed Karandeep Singh as its inaugural chief health AI officer. Singh is a nephrologist by training, and he most recently served as associate chief medical information officer for AI at Michigan Medicine.

Promotions
Healthcare guidance company Amino Health named John Asalone as its new CEO. He joined Amino in August as COO. Before that, Asalone was the senior vice president of growth verticals at GoodRx.

Clarify Health promoted Terry Boch, its chief commercial officer, to the role of CEO. He succeeds Jean Drouin, Clarify’s founder. Drouin stepped down from the helm but is remaining on the team as a board member and senior advisor.

Ashley Magargee took over as the new CEO of Genentech. She had been serving as interim CEO ever since Alexander Hardy’s departure in November. Margargee joined the company in 2004 and has held senior management positions at both Roche and Genentech in lifecycle management, digital customer experience and market access.

Johns Hopkins Medicine named Theodore DeWeese as its new CEO. He joined Johns Hopkins in 1991 as a radiation oncology resident.

Following its acquisition of Seagen, Pfizer announced that it is creating a new business unit dedicated to the development and commercialization of its oncology drugs. This new division, called the Pfizer Oncology Division, will be led by Chris Boshoff, and his new title is chief oncology officer. He’s been at Pfizer for more than a decade.

Departures
At Verily, Amy Abernathy is stepping down from her roles as president of product development and chief medical officer. Abernathy, who previously served as the FDA’s principal deputy commissioner and acting chief information officer, said that she will now start a nonprofit focused on improving the way healthcare data is collected.

Layoffs
Genetic testing company Invitae laid off 15% of its staff as part of a cost-cutting plan.
Kaiser Permanente made two layoff announcements in December. The first is that the health system plans to eliminate 115 IT positions. The second is that it plans to lay off 79 administrative employees across California.

Novant Health is outsourcing its IT operations, which will result in employee layoffs, but the health system hasn’t disclosed the number of positions that will be affected.

Tower Health said it is eliminating 30 roles. This is Tower’s second round of layoffs this year — it let go of 45 workers and eliminated 55 positions through attrition and voluntary departures in April.